Led · Equity · Jul 2026

Founded in July 2021, Neverhack positions itself at the intersection of cybersecurity, artificial intelligence and trusted European infrastructure. The company develops AI-enabled capabilities for detection, incident response, audit and other security operations, and emphasizes sovereign deployments with localized GPU capacity. Neverhack reported over 1,200 employees, operations across 12 countries and €220 million in revenue, and says it supports more than 80% of the SBF 120 with clients including Naval Group, Thales and Airbus. Its near-term plans announced alongside the June 2026 fundraising include industrializing AI cyber solutions, deploying GPU-equipped infrastructures in France, Italy and Estonia, and expanding technical and commercial teams. Leadership changes effective July 21, 2026, assign Arthur Bataille as Executive Chairman and Frédéric Sarrailh as CEO to separate long-term vision from day-to-day execution.

Participated · Series B · Jun 2024

康健苗苗（杭州）医药有限公司, founded in 2014, focuses on the oral-health sector and offers an oral comprehensive platform, dental digitalization systems, and end-to-end dental product customization. The company says it has built a full ecosystem linking dentists and dental clinics. Its legal representative is 林小平, who is also the largest shareholder holding 51.01% of shares. The firm’s registered capital is RMB 14.7036 million. 康健苗苗 has three extant external investments: 汉斯夫（杭州）医学科技有限公司, 袋鼠苗苗（杭州）数据服务有限公司, and 美苗苗（杭州）齿科器械有限公司. Going forward the company plans to upgrade its platform information technology and adapt its services toward more customized offerings. 康健苗苗 operates an oral/dental data services platform built around its e‑commerce channel “梅苗苗” and digital dental solutions. The company has provided online procurement and value‑added services for dental instruments, consumables, drugs and equipment to over 50,000 domestic dental clinics. It has established six logistics centers nationwide, a near‑100‑person R&D team and three digital laboratories to develop dental data products and systems. The firm is developing an AI, big‑data and cloud‑based dental data platform and DaaS system to expand from B2B clinic services toward supporting individual dentists (To D). Future plans include continued R&D and production of digital dental products, medical and data services, and expanding the scale of its e‑commerce business. The company launched in August 2017 and has pursued strategic partnerships, including an exclusive China distribution and supply‑chain cooperation with Korea’s listed DIO.